< -5%

-5% to -3%

-3% to 0%

New India Assur

Go Digit

ICICI Lombard 

0% to 3%

PB Fintech

3% to 5%

Kalyan Jewellers shares jumped nearly 12 percent after strong Q3 FY26 results, Q3 net profit rose over 90 percent YoY to Rs 416.3 crore; revenue up 42 percent, Brokerages keep 'Buy' calls due to strong growth and solid demand momentum.

* Kalyan Jewellers shares jumped nearly 12 percent after strong Q3 FY26 results
* Q3 net profit rose over 90 percent YoY to Rs 416.3 crore; revenue up 42 percent
* Brokerages keep 'Buy' calls due to strong growth and solid demand momentum.

Kalyan Jewellers shares surged nearly 12% after strong Q3 FY26 results, with net profit up 90% YoY and revenue rising 42%. Brokerages maintained 'Buy' ratings, citing robust growth, healthy demand, and positive outlook despite gold price volatility.

shorts/business/kalyan-jewellers-shares-jump-12-after-q3-results-beat-estimates-check-latest-target-prices

* Kalyan Jewellers shares jumped nearly 12 percent after strong Q3 FY26 results
* Q3 net profit rose over 90 percent YoY to Rs 416.3 crore; revenue up 42 percent
* Brokerages keep 'Buy' calls due to strong growth and solid demand momentum.

The shares of <a href="https://www.moneycontrol.com/india/stockpricequote/diamondjewellery/kalyanjewellersindia/KJI01">Kalyan Jewellers India</a> jumped nearly 12 percent on February 9 after the company reported strong results for the October-December quarter of the ongoing financial year 2026.

The shares of the company rose to Rs 424.70 apiece in the morning trading hours of Monday. This is the highest level seen by the stock since January 21.
<h3><strong>Kalyan Jewellers Q3 Results:</strong></h3>
Kalyan Jewellers on February 6 reported a <a href="https://www.moneycontrol.com/news/business/earnings/kalyan-jewellers-india-q3-net-profit-nearly-doubles-yoy-to-rs-416-crore-inventory-gains-help-13815213.html">consolidated net profit of Rs 416.3 crore</a> for the October-December quarter of the ongoing financial year 2026. This marks a jump of more than 90 percent year-on-year (YoY) from the Rs 218.8 crore net profit reported in the same period of the previous financial year.

The firm’s revenue from operations meanwhile grew more than 42 percent YoY to Rs 10,343.4 crore in Q3 FY26 from Rs 7,278.1 crore in Q3 FY25.
<h3><strong>JM Financial on Kalyan Jewellers:</strong></h3>
JM Financial said that Kalyan Jewellers posted Q3 FY26 operational results which were ahead of its estimates with strong revenue growth of 40 percent-plus unleashing operating leverage and benefits of debt repayment beginning to kick in.

"Management highlighted sustained strong growth in Jan’26 in the face of volatility in gold prices, and noted they expect to end FY26 on a good note. SSSG growth also remained robust across regions with India registering SSSG of 27% YoY with 24% YoY SSSG for the Middle East. Candere is also shaping up along expectations and turned PAT-positive this quarter in line with guidance. Debt repayment plans stay intact with a target to be net debt-free by end-FY27E led by a combination of sale of non-core assets and cash flows. The regional brand will see some store openings in Q4FY26E with a total of four–five stores to be opened over one year initially," it said.

The domestic brokerage raised FY26–28E EPS by 4–5 percent given the robust revenue growth momentum. However, it reduced its target price for the stock to Rs 750 per share from Rs 775 per share, based on a cut in target P/E to 40x (due to higher beta over last 6M; from 45x) along with a rollover to Dec’27E EPS, while maintaining its ‘Buy’ call. The latest target price implies an upside potential of more than 97 percent from the stock’s previous closing price.
<h3><strong>Motilal Oswal on Kalyan Jewellers:</strong></h3>
Motilal Oswal kept a ‘Buy’ call on the stock, statin that the company delivered an “all-round beat” through its earnings. “Management indicated that on-ground demand momentum remained healthy in 3QFY26. During the 30 days leading up to Diwali, the company reported LFL growth of over 30%, reflecting strong festive traction. Demand in Jan’26 also remained robust, supported by healthy consumer footfalls despite volatility in gold prices,” it said.

“With the successful scale-up of franchise businesses (&gt;50% revenue contribution) and stable success in non-Southern markets, the company has established itself as a leading brand in the industry. Consistent success on customer acquisition, improving operating margin, and deleveraging balance sheet remain the key rationale for our constructive view on the business. We model a 21%/18%/22% revenue/EBITDA/PAT CAGR during FY26-28E. We reiterate our BUY rating with a TP of INR600 (based on 35x Dec’27 P/E),” it added.

Follow all <a href="https://www.moneycontrol.com/news/business/markets/stock-market-live-updates-gift-nifty-indicates-a-gap-up-start-us-asian-markets-gain-liveblog-13817633.html">LIVE updates</a> from the stock markets here.

<em>Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.</em>

Ownership, Material Conflicts of Interest and Disciplinary History

MCD is a wholly owned subsidiary of Network 18 Media & Investments Ltd ("Network18"), in which Independent Media Trust (IMT) holds 56.89% stake. Reliance Industries Limited ("RIL") is the sole beneficiary of IMT. Network18 and RIL and their subsidiaries, joint ventures and associates can be considered as associates of MCD.

Details of Associate

Receipt of Compensation

Third-Party Compensation

Employment History

Market-Making Activities

Use of Artificial Intelligence

Kalyan Jewellers shares jump 12% after Q3 results beat estimates: Check latest target prices

Kalyan Jewellers share price jumps 12% after Q3 results beat estimates: Check latest target prices

The shares of Kalyan Jewellers India jumped nearly 12 percent on February 9 after the company reported strong results for the October-December quarter of the ongoing financial year 2026.

The shares of the company rose to Rs 424.70 apiece in the morning trading hours of Monday. This is the highest level seen by the stock since January 21.
Kalyan Jewellers Q3 Results:
Kalyan Jewellers on February 6 reported a consolidated net profit of Rs 416.3 crore for the October-December quarter of the ongoing financial year 2026. This marks a jump of more than 90 percent year-on-year (YoY) from the Rs 218.8 crore net profit reported in the same period of the previous financial year.

The firm’s revenue from operations meanwhile grew more than 42 percent YoY to Rs 10,343.4 crore in Q3 FY26 from Rs 7,278.1 crore in Q3 FY25.
JM Financial on Kalyan Jewellers:
JM Financial said that Kalyan Jewellers posted Q3 FY26 operational results which were ahead of its estimates with strong revenue growth of 40 percent-plus unleashing operating leverage and benefits of debt repayment beginning to kick in.

&quot;Management highlighted sustained strong growth in Jan’26 in the face of volatility in gold prices, and noted they expect to end FY26 on a good note. SSSG growth also remained robust across regions with India registering SSSG of 27% YoY with 24% YoY SSSG for the Middle East. Candere is also shaping up along expectations and turned PAT-positive this quarter in line with guidance. Debt repayment plans stay intact with a target to be net debt-free by end-FY27E led by a combination of sale of non-core assets and cash flows. The regional brand will see some store openings in Q4FY26E with a total of four–five stores to be opened over one year initially,&quot; it said.

The domestic brokerage raised FY26–28E EPS by 4–5 percent given the robust revenue growth momentum. However, it reduced its target price for the stock to Rs 750 per share from Rs 775 per share, based on a cut in target P/E to 40x (due to higher beta over last 6M; from 45x) along with a rollover to Dec’27E EPS, while maintaining its ‘Buy’ call. The latest target price implies an upside potential of more than 97 percent from the stock’s previous closing price.
Motilal Oswal on Kalyan Jewellers:
Motilal Oswal kept a ‘Buy’ call on the stock, statin that the company delivered an “all-round beat” through its earnings. “Management indicated that on-ground demand momentum remained healthy in 3QFY26. During the 30 days leading up to Diwali, the company reported LFL growth of over 30%, reflecting strong festive traction. Demand in Jan’26 also remained robust, supported by healthy consumer footfalls despite volatility in gold prices,” it said.

“With the successful scale-up of franchise businesses (&amp;gt;50% revenue contribution) and stable success in non-Southern markets, the company has established itself as a leading brand in the industry. Consistent success on customer acquisition, improving operating margin, and deleveraging balance sheet remain the key rationale for our constructive view on the business. We model a 21%/18%/22% revenue/EBITDA/PAT CAGR during FY26-28E. We reiterate our BUY rating with a TP of INR600 (based on 35x Dec’27 P/E),” it added.

Follow all LIVE updates from the stock markets here.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

SBI's market cap surpasses Rs10 lakh crore, now India's 6th most valuable firm., SBI overtakes ICICI Bank as second-most valuable bank after strong Q3 earnings, SBI shares hit record high, driven by robust profit and improved asset quality

* SBI's market cap surpasses Rs10 lakh crore, now India's 6th most valuable firm.
* SBI overtakes ICICI Bank as second-most valuable bank after strong Q3 earnings
* SBI shares hit record high, driven by robust profit and improved asset quality

State Bank of India’s market cap crossed Rs10 lakh crore, making it India’s sixth most valuable listed firm. SBI overtook ICICI Bank as the second-most valuable bank, driven by strong earnings, improved asset quality, and robust credit growth.

shorts/business/sbi-becomes-sixth-indian-firm-to-cross-rs-10-lakh-crore-mcap

* SBI's market cap surpasses Rs10 lakh crore, now India's 6th most valuable firm.
* SBI overtakes ICICI Bank as second-most valuable bank after strong Q3 earnings
* SBI shares hit record high, driven by robust profit and improved asset quality

With its market capitalisation crossing Rs 10 lakh crore, State Bank of India has entered the ranks of India’s most valuable listed companies. The milestone places the state-owned lender alongside Reliance Industries, HDFC Bank, Bharti Airtel, Tata Consultancy Services, and ICICI Bank, making it the sixth Indian firm to achieve the feat.

The state-owned lender also regained its position as the second-most valuable bank by mcap, overtaking ICICI Bank after a gap of more than six years. Earlier, on August 6, 2019, SBI’s market capitalisation stood at Rs 2.69 trillion, slightly above ICICI Bank’s Rs 2.65 trillion.

SBI’s mcap stood at about Rs 10.4 lakh crore, ahead of ICICI Bank’s Rs10.03 lakh crore, according to exchange data. HDFC Bank remains the most valuable bank, with a mcap of Rs 14.47 lakh crore.

SBI shares hit a record high of Rs 1,137 on the BSE, rising 6 percent in a single session following strong December quarter earnings. The stock has gained about 15 percent so far in 2026, after rising more than 25 percent in 2025.

The lender reported a strong performance in the third quarter of FY26, with profit after tax rising 24 percent year-on-year and 4 percent quarter-on-quarter, coming in about 25 percent above analyst estimates. Earnings were supported by one-off items, including dividend income of Rs22 billion, an income-tax refund of Rs7.7 billion, and lower employee benefit provisions of Rs14.3 billion quarter-on-quarter. Even after adjusting for these one-offs, profit remained about 5 percent above estimates.

Net interest income rose 9 percent year-on-year and 5 percent quarter-on-quarter, broadly in line with expectations, aided by strong loan growth of 16 percent year-on-year and 6 percent quarter-on-quarter, along with a 5 basis point sequential expansion in net interest margins. Pre-provision operating profit surged 40 percent year-on-year and 20 percent quarter-on-quarter, supported by strong treasury and foreign exchange income and controlled employee costs.

Asset quality continued to improve, with both gross and net slippages declining by 3 basis points sequentially, while credit costs fell by 10 basis points quarter-on-quarter to 0.40 percent. Management raised its FY26 credit growth guidance to 13 to 15 percent and maintained its exit net interest margin guidance of around 3 percent.

JM Financial said stable margins, efficient cost management, and benign credit costs are expected to support consistent profitability, with average return on assets and return on equity of about 1.0 percent and 15 percent, respectively, over FY27–FY28. The brokerage maintained a buy rating on the stock with a revised target price of Rs 1,250, valuing the core bank at 1.4 times FY28 estimated standalone book value per share.

JM Financial added that strong and diversified growth, resilient margins despite deposit pressures, industry-leading asset quality and sizeable provision buffers underpin SBI’s improved earnings visibility and balance-sheet strength.

Motilal Oswal said SBI delivered a strong all-round performance, led by robust business growth, margin expansion and healthy asset quality. The brokerage noted that net interest margin expanded 2 basis points quarter-on-quarter to 2.99 percent, with domestic margins at 3.12 percent. It said SBI expects net interest margins to remain at 3 percent or higher in FY26 and over the long term.

Motilal Oswal added that credit growth remained healthy at 15.6 percent year-on-year, supported by a strong pipeline, while asset quality continued to improve with benign credit costs of 29 basis points. The brokerage raised its earnings estimates by 3 percent and 4.3 percent for FY27 and FY28, respectively, and reiterated a buy rating with a revised target price of Rs 1,300.

Currently, SBI has 42 buy ratings and seven hold ratings, with no sell recommendations. ICICI Bank has 48 buy ratings and two hold ratings, with no sell ratings, according to analyst data.

SBI becomes sixth Indian firm to cross Rs 10 lakh crore mcap

With its market capitalisation crossing Rs 10 lakh crore, State Bank of India has entered the ranks of India’s most valuable listed companies. The milestone places the state-owned lender alongside Reliance Industries, HDFC Bank, Bharti Airtel, Tata Consultancy Services, and ICICI Bank, making it the sixth Indian firm to achieve the feat.

The state-owned lender also regained its position as the second-most valuable bank by mcap, overtaking ICICI Bank after a gap of more than six years. Earlier, on August 6, 2019, SBI’s market capitalisation stood at Rs 2.69 trillion, slightly above ICICI Bank’s Rs 2.65 trillion.

SBI’s mcap stood at about Rs 10.4 lakh crore, ahead of ICICI Bank’s Rs10.03 lakh crore, according to exchange data. HDFC Bank remains the most valuable bank, with a mcap of Rs 14.47 lakh crore.

SBI shares hit a record high of Rs 1,137 on the BSE, rising 6 percent in a single session following strong December quarter earnings. The stock has gained about 15 percent so far in 2026, after rising more than 25 percent in 2025.

The lender reported a strong performance in the third quarter of FY26, with profit after tax rising 24 percent year-on-year and 4 percent quarter-on-quarter, coming in about 25 percent above analyst estimates. Earnings were supported by one-off items, including dividend income of Rs22 billion, an income-tax refund of Rs7.7 billion, and lower employee benefit provisions of Rs14.3 billion quarter-on-quarter. Even after adjusting for these one-offs, profit remained about 5 percent above estimates.

Net interest income rose 9 percent year-on-year and 5 percent quarter-on-quarter, broadly in line with expectations, aided by strong loan growth of 16 percent year-on-year and 6 percent quarter-on-quarter, along with a 5 basis point sequential expansion in net interest margins. Pre-provision operating profit surged 40 percent year-on-year and 20 percent quarter-on-quarter, supported by strong treasury and foreign exchange income and controlled employee costs.

Asset quality continued to improve, with both gross and net slippages declining by 3 basis points sequentially, while credit costs fell by 10 basis points quarter-on-quarter to 0.40 percent. Management raised its FY26 credit growth guidance to 13 to 15 percent and maintained its exit net interest margin guidance of around 3 percent.

JM Financial said stable margins, efficient cost management, and benign credit costs are expected to support consistent profitability, with average return on assets and return on equity of about 1.0 percent and 15 percent, respectively, over FY27–FY28. The brokerage maintained a buy rating on the stock with a revised target price of Rs 1,250, valuing the core bank at 1.4 times FY28 estimated standalone book value per share.

JM Financial added that strong and diversified growth, resilient margins despite deposit pressures, industry-leading asset quality and sizeable provision buffers underpin SBI’s improved earnings visibility and balance-sheet strength.

Motilal Oswal said SBI delivered a strong all-round performance, led by robust business growth, margin expansion and healthy asset quality. The brokerage noted that net interest margin expanded 2 basis points quarter-on-quarter to 2.99 percent, with domestic margins at 3.12 percent. It said SBI expects net interest margins to remain at 3 percent or higher in FY26 and over the long term.

Motilal Oswal added that credit growth remained healthy at 15.6 percent year-on-year, supported by a strong pipeline, while asset quality continued to improve with benign credit costs of 29 basis points. The brokerage raised its earnings estimates by 3 percent and 4.3 percent for FY27 and FY28, respectively, and reiterated a buy rating with a revised target price of Rs 1,300.

Currently, SBI has 42 buy ratings and seven hold ratings, with no sell recommendations. ICICI Bank has 48 buy ratings and two hold ratings, with no sell ratings, according to analyst data.

SBI shares jumped nearly 7 percent after record Q3 net profit and strong results, Brokerages raised targets due to strong loan growth and better asset quality., SBI's Q3 net profit rose 24.49 percent YoY to Rs 21,028.15 crore, highest ever

* SBI shares jumped nearly 7 percent after record Q3 net profit and strong results
* Brokerages raised targets due to strong loan growth and better asset quality.
* SBI's Q3 net profit rose 24.49 percent YoY to Rs 21,028.15 crore, highest ever

SBI shares surged nearly 7% to a record high after Q3 results beat expectations, with net profit up 24.49% YoY to Rs 21,028 crore. Brokerages raised target prices, citing strong loan growth, improved asset quality, and robust earnings.

shorts/business/sbi-shares-jump-7-to-record-high-after-lender-posts-highest-ever-quarterly-profit-in-q3-brokerages-raise-target-prices

* SBI shares jumped nearly 7 percent after record Q3 net profit and strong results
* Brokerages raised targets due to strong loan growth and better asset quality.
* SBI's Q3 net profit rose 24.49 percent YoY to Rs 21,028.15 crore, highest ever

The shares of State Bank of India (<a href="https://www.moneycontrol.com/india/stockpricequote/banks-public-sector/statebankindia/SBI">SBI</a>) jumped nearly 7 percent to a fresh record high on February 9 after the public lender’s Q3 results surpassed expectations. Several brokerages raised their target prices for the stock.

The shares of the company hit a fresh 52-week high of Rs 1,137 apiece in the morning trading hours of Monday.
<h3><strong>SBI Q3 Results:</strong></h3>
SBI on February 7 reported a net profit after minority interest of Rs 21,028.15 crore for the October-December quarter of the ongoing financial year 2026. This is the highest-ever quaterly net profit reported by the banking behemoth.

This marks a <a href="https://www.moneycontrol.com/news/business/earnings/sbi-q3fy26-profit-jumps-24-5-to-rs-21-028-crore-gross-npa-ratio-improves-to-1-57-13816638.html">24.49 percent year-on-year (YoY) increase</a> from the Rs 16,891.44 crore net profit reported in the same quarter of the previous financial year.

The public lender’s net interest income (NII) meanwhile grew 9 percent YoY to Rs 45,190 crore during the quarter under review from Rs 41,445 crore in the year-ago period, reflecting steady growth in core lending income.

Sequentially, SBI’s asset quality improved, with gross NPA ratio improving to 1.57 percent in Q3 FY26 from 1.73 percent in Q2 FY26. Net NPA ratio meanwhile declined to 0.39 percent in Q3 FY26 from 0.42 percent in Q2 FY26.

Provisions for the quarter stood at Rs 4,506 crore, lower than Rs 5,400 crore in the previous quarter and sharply down from Rs 911 crore a year earlier, indicating easing credit costs.

The bank's management also raised SBI's loan growth guidance for FY26 to 13–15 percent, from the earlier 12–14 percent.
<h3><strong>Nomura on SBI:</strong></h3>
Nomura maintained its ‘Buy’ call on SBI shares, while raising its target price to Rs 1,235 apiece. This implies an upside potential of nearly 16 percent from the stock’s previous closing price.

The international brokerage said that the company delivered an “strong all-round” performance during the quarter, with better margin delivery and loan growth in comparison to its peers. It added that strong NIM performance, controlled opex and higher other income drove a beat on profit after tax.

Nomura further noted that loan growth was strong and broad based, while asset quality remained stable. Incremental upside is expected to be largely earnings-driven, rather than multiple-led, it added.
<h3><strong>CLSA on SBI:</strong></h3>
CLSA maintained an ‘Outperform’ rating on the stock, while raising its target price to Rs 1,275 apiece. This implies an upside potential of nearly 20 percent from the stock’s previous closing price.

The international brokerage said that the lender posted Stronger-than-expected Q3 results, with core PPoP and PBT beating estimates by 4-11 percent.

Loan growth picked up from 13 percent to 15 percent YoY, and sequential loan growth outperformed PSU peers as well as large private banks, it added. Margin improved 2 bps QoQ to 3 percent due to a lower cost of deposits, it said, adding that slippages declined sequentially and credit costs were much better than expected.
<h3><strong>Citi on SBI:</strong></h3>
Citi kept a ‘Buy’ call on SBI shares, and raised its target price to Rs 1,265 per share. This implies an upside potential of nearly 19 percent from the stock’s previous closing price.

The international brokerage said that the lender’s core earni9ngs surpassed expectations. Broad-based growth across SME, corporate, agri &amp; Xpress credit led management to raise FY26 loan growth guidance to 13-15 percent, it added.

Citi added that NIMs are expected to sustain at or above 3 percent. Disciplined underwriting and recoveries should support asset quality, it said.
<h3><strong>Jefferies on SBI:</strong></h3>
Jefferies kept a ‘Buy’ call on SBI shares, and raised its target price for the stock to Rs 1,300 apiece. This implies an upside potential of nearly 22 percent from the stock’s previous closing price.

The international brokerage said that the firm’s Q3 results beat estimates, driven by higher other income and lower credit costs. Loan growth improved to 15 percent, NII growth was the leading among the peers at 9 percent, fees grew 16 percent and credit costs remained low, it added.
<h3><strong>Nuvama on SBI:</strong></h3>
Nuvama kept a ‘Buy’ call on SBI shares, and raised its target price to Rs 1,250 per share. The international brokerage said that the lender posted strong core earnings with 6 percent QoQ loan growth and 5 percent QoQ NII growth.

It added that PAT was above estimate due to a Rs 2,200 crore dividend from SBI AMC and Rs 770 crore interest on tax refunds. Reported NIM rose 2 bps QoQ, while core NIM ex-refund dipped.

Follow all <a href="https://www.moneycontrol.com/news/business/markets/stock-market-live-updates-gift-nifty-indicates-a-gap-up-start-us-asian-markets-gain-liveblog-13817633.html">LIVE updates</a> on stock markets here.

<em>Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.</em>

SBI shares jump 7% to record high after lender posts highest-ever quarterly profit in Q3: Brokerages raise target prices

SBI share price jumps 7% to record high after lender posts highest-ever quarterly profit in Q3: Brokerages raise target prices

The shares of State Bank of India (SBI) jumped nearly 7 percent to a fresh record high on February 9 after the public lender’s Q3 results surpassed expectations. Several brokerages raised their target prices for the stock.

The shares of the company hit a fresh 52-week high of Rs 1,137 apiece in the morning trading hours of Monday.
SBI Q3 Results:
SBI on February 7 reported a net profit after minority interest of Rs 21,028.15 crore for the October-December quarter of the ongoing financial year 2026. This is the highest-ever quaterly net profit reported by the banking behemoth.

This marks a 24.49 percent year-on-year (YoY) increase from the Rs 16,891.44 crore net profit reported in the same quarter of the previous financial year.

The public lender’s net interest income (NII) meanwhile grew 9 percent YoY to Rs 45,190 crore during the quarter under review from Rs 41,445 crore in the year-ago period, reflecting steady growth in core lending income.

Sequentially, SBI’s asset quality improved, with gross NPA ratio improving to 1.57 percent in Q3 FY26 from 1.73 percent in Q2 FY26. Net NPA ratio meanwhile declined to 0.39 percent in Q3 FY26 from 0.42 percent in Q2 FY26.

Provisions for the quarter stood at Rs 4,506 crore, lower than Rs 5,400 crore in the previous quarter and sharply down from Rs 911 crore a year earlier, indicating easing credit costs.

The bank's management also raised SBI's loan growth guidance for FY26 to 13–15 percent, from the earlier 12–14 percent.
Nomura on SBI:
Nomura maintained its ‘Buy’ call on SBI shares, while raising its target price to Rs 1,235 apiece. This implies an upside potential of nearly 16 percent from the stock’s previous closing price.

The international brokerage said that the company delivered an “strong all-round” performance during the quarter, with better margin delivery and loan growth in comparison to its peers. It added that strong NIM performance, controlled opex and higher other income drove a beat on profit after tax.

Nomura further noted that loan growth was strong and broad based, while asset quality remained stable. Incremental upside is expected to be largely earnings-driven, rather than multiple-led, it added.
CLSA on SBI:
CLSA maintained an ‘Outperform’ rating on the stock, while raising its target price to Rs 1,275 apiece. This implies an upside potential of nearly 20 percent from the stock’s previous closing price.

The international brokerage said that the lender posted Stronger-than-expected Q3 results, with core PPoP and PBT beating estimates by 4-11 percent.

Loan growth picked up from 13 percent to 15 percent YoY, and sequential loan growth outperformed PSU peers as well as large private banks, it added. Margin improved 2 bps QoQ to 3 percent due to a lower cost of deposits, it said, adding that slippages declined sequentially and credit costs were much better than expected.
Citi on SBI:
Citi kept a ‘Buy’ call on SBI shares, and raised its target price to Rs 1,265 per share. This implies an upside potential of nearly 19 percent from the stock’s previous closing price.

The international brokerage said that the lender’s core earni9ngs surpassed expectations. Broad-based growth across SME, corporate, agri &amp;amp; Xpress credit led management to raise FY26 loan growth guidance to 13-15 percent, it added.

Citi added that NIMs are expected to sustain at or above 3 percent. Disciplined underwriting and recoveries should support asset quality, it said.
Jefferies on SBI:
Jefferies kept a ‘Buy’ call on SBI shares, and raised its target price for the stock to Rs 1,300 apiece. This implies an upside potential of nearly 22 percent from the stock’s previous closing price.

The international brokerage said that the firm’s Q3 results beat estimates, driven by higher other income and lower credit costs. Loan growth improved to 15 percent, NII growth was the leading among the peers at 9 percent, fees grew 16 percent and credit costs remained low, it added.
Nuvama on SBI:
Nuvama kept a ‘Buy’ call on SBI shares, and raised its target price to Rs 1,250 per share. The international brokerage said that the lender posted strong core earnings with 6 percent QoQ loan growth and 5 percent QoQ NII growth.

It added that PAT was above estimate due to a Rs 2,200 crore dividend from SBI AMC and Rs 770 crore interest on tax refunds. Reported NIM rose 2 bps QoQ, while core NIM ex-refund dipped.

Follow all LIVE updates on stock markets here.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

<a href="https://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/aurobindopharma/AP">Aurobindo Pharma</a> share price gained marginally on February 9 despite the company received 11 observations following an inspection from United States Food and Drug Administration (USFDA).

At 09:30am, Aurobindo Pharma was quoting at Rs 1,195, up Rs 3.85, or 0.32 percent, on the BSE.

The USFDA inspected unit-III, a formulation manufacturing facility, of Eugia Pharma Specialities, a wholly owned subsidiary of the company, situated at Telangana.

The said inspection done between January 27 to February 06, 2026.

The inspection concluded with 11 observations, which are procedural in nature and will be responded to within the stipulated time, company said.

<strong><a href="https://www.moneycontrol.com/news/business/markets/stock-market-live-updates-gift-nifty-indicates-a-gap-up-start-us-asian-markets-gain-liveblog-13817633.html">Catch all the market action on our live blog</a></strong>

In the previous trading session, the stock closed at ₹1,191.15, gaining ₹8.65, or 0.73 percent. The share has touched a 52-week high of ₹1,278 on April 24, 2025, and a 52-week low of ₹994.35 on April 7, 2025.

At current levels, the stock is trading about 6.8 percent below its 52-week high and nearly 19.79 percent above its 52-week low. The company’s market capitalisation stands at ₹69,182.19 crore.

Aurobindo Pharma receives 11 observations from USFDA; stock price flat

Aurobindo Pharma share price gained marginally on February 9 despite the company received 11 observations following an inspection from United States Food and Drug Administration (USFDA).

At 09:30am, Aurobindo Pharma was quoting at Rs 1,195, up Rs 3.85, or 0.32 percent, on the BSE.

The USFDA inspected unit-III, a formulation manufacturing facility, of Eugia Pharma Specialities, a wholly owned subsidiary of the company, situated at Telangana.

The said inspection done between January 27 to February 06, 2026.

The inspection concluded with 11 observations, which are procedural in nature and will be responded to within the stipulated time, company said.

Catch all the market action on our live blog

In the previous trading session, the stock closed at ₹1,191.15, gaining ₹8.65, or 0.73 percent. The share has touched a 52-week high of ₹1,278 on April 24, 2025, and a 52-week low of ₹994.35 on April 7, 2025.

At current levels, the stock is trading about 6.8 percent below its 52-week high and nearly 19.79 percent above its 52-week low. The company’s market capitalisation stands at ₹69,182.19 crore.

<a href="https://www.moneycontrol.com/india/stockpricequote/auto-lcvshcvs/forcemotors/FM01">Force Motors</a>’ share price touched 52-week high of Rs 22,200 after the company entered into a Memorandum of Understanding (MoU) to acquire full control of Veera Tanneries.

At 09:29 hrs Force Motors was quoting at Rs 21,849.95, up Rs 431.10, or 2.01 percent, on the BSE.

Force Motors, Veera Tanneries (VTPL), and the shareholders of VTPL executed the MoU on Friday, February 6, 2026, for the acquisition of 100% equity stake in VTPL. The total consideration for the transaction stands at Rs 175 crore.

<strong><a href="https://www.moneycontrol.com/news/business/markets/stock-market-live-updates-gift-nifty-indicates-a-gap-up-start-us-asian-markets-gain-liveblog-13817633.html">Catch all the market action on our live blog</a></strong>

For the quarter ended December (Q3FY26), the company reported a 252% surge in consolidated net profit to Rs 406.1 crore, compared with Rs 115.3 crore in the corresponding period last year.

Revenue rose 12.7% year-on-year to Rs 2,128.6 crore, up from Rs 1,889.5 crore.

The performance was supported by exceptional gains of Rs 211.2 crore, as against nil in the year-ago quarter.

The company’s total sales for January rose 4.6% year-on-year to 3,764 units, compared with 3,597 units in the same month last year.

Domestic sales increased 4.92% to 3,665 units, while exports declined 4.81% to 99 units, down from 104 units a year ago.

The share price surged 230 percent in the last one-year.

Force Motors shares hit 52-week high on plan to acquire 100% stake in Veera Tanneries

Force Motors’ share price touched 52-week high of Rs 22,200 after the company entered into a Memorandum of Understanding (MoU) to acquire full control of Veera Tanneries.

At 09:29 hrs Force Motors was quoting at Rs 21,849.95, up Rs 431.10, or 2.01 percent, on the BSE.

Force Motors, Veera Tanneries (VTPL), and the shareholders of VTPL executed the MoU on Friday, February 6, 2026, for the acquisition of 100% equity stake in VTPL. The total consideration for the transaction stands at Rs 175 crore.

Catch all the market action on our live blog

For the quarter ended December (Q3FY26), the company reported a 252% surge in consolidated net profit to Rs 406.1 crore, compared with Rs 115.3 crore in the corresponding period last year.

Revenue rose 12.7% year-on-year to Rs 2,128.6 crore, up from Rs 1,889.5 crore.

The performance was supported by exceptional gains of Rs 211.2 crore, as against nil in the year-ago quarter.

The company’s total sales for January rose 4.6% year-on-year to 3,764 units, compared with 3,597 units in the same month last year.

Domestic sales increased 4.92% to 3,665 units, while exports declined 4.81% to 99 units, down from 104 units a year ago.

The share price surged 230 percent in the last one-year.

Multiline Insurance & Brokers Industry Stocks
Check latest stock performance, list of stocks, earnings review & more details about the Multiline Insurance & Brokers industry stocks.

Gainers/Losers

Industry Market Map

Earnings Review-Q3 FY25-26

Stock News

Kalyan Jewellers shares jump 12% after Q3 results beat estimates: Check latest target prices

SBI becomes sixth Indian firm to cross Rs 10 lakh crore mcap

SBI shares jump 7% to record high after lender posts highest-ever quarterly profit in Q3: Brokerages raise target prices

Aurobindo Pharma receives 11 observations from USFDA; stock price flat

Force Motors shares hit 52-week high on plan to acquire 100% stake in Veera Tanneries

Multiline Insurance & Brokers Industry StocksCheck latest stock performance, list of stocks, earnings review & more details about the Multiline Insurance & Brokers industry stocks.

Gainers/Losers

Industry Market Map

Earnings Review-Q3 FY25-26

Stock News

Kalyan Jewellers shares jump 12% after Q3 results beat estimates: Check latest target prices

SBI becomes sixth Indian firm to cross Rs 10 lakh crore mcap

SBI shares jump 7% to record high after lender posts highest-ever quarterly profit in Q3: Brokerages raise target prices

Aurobindo Pharma receives 11 observations from USFDA; stock price flat

Force Motors shares hit 52-week high on plan to acquire 100% stake in Veera Tanneries

Multiline Insurance & Brokers Industry Stocks
Check latest stock performance, list of stocks, earnings review & more details about the Multiline Insurance & Brokers industry stocks.